{
    "root": "67a52e71-74e5-4790-accf-dc9f2f761705",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "Premarin",
        "suffix": {
            "text": "Vaginal"
        }
    },
    "value": "20250502",
    "ingredients": [
        {
            "name": "ESTROGENS, CONJUGATED",
            "code": "IU5QR144QX"
        },
        {
            "name": "CETYL ALCOHOL",
            "code": "936JST6JCN"
        },
        {
            "name": "WHITE WAX",
            "code": "7G1J5DA97F"
        },
        {
            "name": "GLYCERYL MONOSTEARATE",
            "code": "230OU9XXE4"
        },
        {
            "name": "PROPYLENE GLYCOL MONOPALMITOSTEARATE",
            "code": "F76354LMGR"
        },
        {
            "name": "METHYL STEARATE",
            "code": "8D4NXF3ZH7"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "MINERAL OIL",
            "code": "T5L8T28FGP"
        }
    ],
    "indications": "premarin ( conjugated estrogens ) vaginal cream mixture estrogens indicated : • treatment atrophic vaginitis kraurosis vulvae ( 1.1 ) • treatment moderate severe dyspareunia , symptom vulvar vaginal atrophy , due menopause ( 1.2 )",
    "contraindications": "generally , estrogen prescribed postmenopausal woman uterus , progestin also considered reduce risk endometrial cancer [ boxed warning ] . woman without uterus need progestin . cases , however , hysterectomized women history endometriosis may need progestin [ ( 5.3 , 5.15 ) ] . estrogen-alone , combination progestin , lowest effective dose shortest duration consistent treatment goals risks individual woman . postmenopausal women re-evaluated periodically clinically appropriate determine treatment still necessary .",
    "warningsAndPrecautions": null,
    "adverseReactions": "premarin vaginal cream contraindicated women following conditions : • undiagnosed abnormal genital bleeding [ ( 5.3 ) ] • breast cancer history breast cancer [ ( 5.3 ) ] • estrogen-dependent neoplasia [ ( 5.3 ) ] • active dvt , pe , history conditions [ ( 5.2 ) ] • active arterial thromboembolic disease ( example , stroke myocardial infarction ) , history conditions [ ( 5.2 ) ] • known anaphylactic reaction angioedema premarin [ ( 5.16 , 5.17 ) ] • hepatic impairment disease [ ( 5.11 ) ] • protein c , protein antithrombin deficiency known thrombophilic disorders",
    "indications_original": "PREMARIN (conjugated estrogens) vaginal cream is a mixture of estrogens indicated for: • Treatment of Atrophic Vaginitis and Kraurosis Vulvae ( 1.1 ) • Treatment of Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy, due to Menopause ( 1.2 )",
    "contraindications_original": "Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be considered to reduce the risk of endometrial cancer [see Boxed Warning].\n                  \n                  A woman without a uterus does not need a progestin. In some cases, however, hysterectomized women with a history of endometriosis may need a progestin [see Warnings and Precautions (5.3, 5.15)]. \n                  Use of estrogen-alone, or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Postmenopausal women should be re-evaluated periodically as clinically appropriate to determine if treatment is still necessary.",
    "adverseReactions_original": "PREMARIN vaginal cream is contraindicated in women with any of the following conditions: \n                  \n                     \n                        •\n                        Undiagnosed abnormal genital bleeding [see Warnings and Precautions (5.3)]\n                        \n                     \n                     \n                        •\n                        Breast cancer or a history of breast cancer [see Warnings and Precautions (5.3)]\n                        \n                     \n                     \n                        •\n                        Estrogen-dependent neoplasia [see Warnings and Precautions (5.3)]\n                        \n                     \n                     \n                        •\n                        Active DVT, PE, or a history of these conditions [see Warnings and Precautions (5.2)]\n                        \n                     \n                     \n                        •\n                        Active arterial thromboembolic disease (for example, stroke and MI), or a history of these conditions [see Warnings and Precautions (5.2)]\n                        \n                     \n                     \n                        •\n                        Known anaphylactic reaction or angioedema to PREMARIN [see Warnings and Precautions (5.16,\n                              5.17)]\n                        \n                     \n                     \n                        •\n                        Hepatic impairment or disease [see Warnings and Precautions (5.11)]\n                        \n                     \n                     \n                        •\n                        Protein C, protein S or antithrombin deficiency or other known thrombophilic disorders"
}